vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 103.21% | -319.54% | |||
| Gross Profit | -103.19% | 320.60% | |||
| SG&A Expenses | 37.31% | -18.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 32.47% | -24.55% | |||
| Operating Income | -32.93% | 24.81% | |||
| Income Before Tax | -40.12% | 24.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.12% | 24.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 40.10% | -24.03% | |||
| Net Income | -40.12% | 24.02% | |||
| EBIT | -32.93% | 24.81% | |||
| EBITDA | -33.35% | 24.89% | |||
| EPS Basic | -40.13% | 37.03% | |||
| Normalized Basic EPS | -40.13% | 37.02% | |||
| EPS Diluted | -40.13% | 37.03% | |||
| Normalized Diluted EPS | -40.13% | 37.02% | |||
| Average Basic Shares Outstanding | 0.00% | 20.65% | |||
| Average Diluted Shares Outstanding | 0.00% | 20.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||